|
| |
| Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
| LCA-23-310420 |
NB400-105PEP |
ABCA1// |
1/EA |
|
|
|
 |
¹®ÀÇ |
|
|
|
|
|
|
|
Subject
|
ABCA1 |
|
Description
|
/ |
|
Clonality
|
Mono |
|
Company
|
Novus biologicals |
|
Application
|
|
|
Conjugation
|
|
|
Immunogen
|
|
|
Contents
|
Description: | Manufacturer | Novus Biologicals Inc. | | Quantity | 0.05 mg | | PDF datasheet | view | | Shipping to | Not USA/Canada | | Synonyms | ABC1, ABC-1, CERP | | Swiss Prot Num | O95477 | | Product Type | Antibodies | | Storage | Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | |
| Specificity | , This peptide is specific for NB400-105 only. | | Add. information | Research Areas: Neuroscience, Cellular Markers, Lipid and Metabolism | | Application | , Used as a blocking peptide for NB 400-105 | | Background | Mutations in the ABCA1 gene (ATP-binding cassette transporter 1) have been reported in Tangier disease (TD). TD is an autosomal recessive disorder characterized by an absence of plasma HDL, cholesterol ester depositing in the reticulo-endothelial system | | Concentration | 1 mg/ml | |
| Format | Buffer System: No Preservative | |
|
|
|
|